-
Mashup Score: 2Home – Cell Symposia: The Biology of Neuropsychiatric Disorders - 2 year(s) ago
Cell Symposium: Cell Symposia: Overcoming Drug Resistance in Cancer
Source: www.cell-symposia.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0To treat or not to treat with immunosuppressive therapy: psychiatric disorders in patients with systemic lupus erythematosus - 2 year(s) ago
Up to 65% of patients with SLE meet the criteria for a psychiatric disorder.1 Especially depression and anxiety are frequently present. Psychiatric disorders are important to recognise as they influence quality of life and treatment outcomes. As a myriad of causes may be responsible for psychiatric manifestations in patients with SLE, clinicians are often confronted with the question: to treat or…
Source: Lupus Science & MedicineCategories: Latest Headlines, RheumatologyTweet-
This week on LSM: Letter- data demonstrate that #psychiatric disorders in #SLE are common, especially #cognitive #disorder and #depression, and lead to a high #disease burden in patients referred for assessment of possible #neuropsychiatric #lupus. https://t.co/dcAD7kDYI2
-
-
Mashup Score: 1To treat or not to treat with immunosuppressive therapy: psychiatric disorders in patients with systemic lupus erythematosus - 2 year(s) ago
Up to 65% of patients with SLE meet the criteria for a psychiatric disorder.1 Especially depression and anxiety are frequently present. Psychiatric disorders are important to recognise as they influence quality of life and treatment outcomes. As a myriad of causes may be responsible for psychiatric manifestations in patients with SLE, clinicians are often confronted with the question: to treat or…
Source: Lupus Science & MedicineCategories: Latest Headlines, RheumatologyTweet-
This week on LSM: Letter- data demonstrate that #psychiatric disorders in #SLE are common, especially #cognitive #disorder and #depression, and lead to a high #disease burden in patients referred for assessment of possible #neuropsychiatric #lupus. https://t.co/dcAD7kDqSu
-
-
Mashup Score: 1To treat or not to treat with immunosuppressive therapy: psychiatric disorders in patients with systemic lupus erythematosus - 2 year(s) ago
Up to 65% of patients with SLE meet the criteria for a psychiatric disorder.1 Especially depression and anxiety are frequently present. Psychiatric disorders are important to recognise as they influence quality of life and treatment outcomes. As a myriad of causes may be responsible for psychiatric manifestations in patients with SLE, clinicians are often confronted with the question: to treat or…
Source: Lupus Science & MedicineCategories: Latest Headlines, RheumatologyTweet-
This week on LSM: Letter- data demonstrate that #psychiatric disorders in #SLE are common, especially #cognitive #disorder and #depression, and lead to a high #disease burden in patients referred for assessment of possible #neuropsychiatric #lupus. https://t.co/dcAD7kDqSu
-
-
Mashup Score: 1
The FDA has previously warned of the risk for neuropsychiatric drug reactions for leukotriene receptor antagonists – including a boxed warning for montelukast.
Source: www.mdedge.comCategories: Latest Headlines, NeurologyTweet-
Use of a LTRA for asthma management did not increase the risk of #neuropsychiatric disease, according to over 60K asthma patients. https://t.co/A8NSOoQyWg https://t.co/z1LLmT7Bka
-
-
Mashup Score: 2Leukotriene Receptor Antagonists and the Risk of Neuropsychiatric Disease: Could There Be a Genetic Predisposition? - 2 year(s) ago
Leukotriene receptor antagonists (LTRAs), montelukast, zafirlukast, and pranlukast (specifically in the far East), were launched some 2 decades ago as add-on medication for patients with asthma and allergic rhinitis. LTRAs are relatively benign drugs, but only a subgroup of patients benefits from them, specifically those in whom leukotrienes play an important role in the pathogenesis of their…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue (Free)! #Leukotriene #Receptor #Antagonists and the Risk of #Neuropsychiatric #Disease: Could There Be a #Genetic #Predisposition? https://t.co/4y7ESB0QRs
-
-
Mashup Score: 0
Although a leukotriene receptor antagonist (LTRA) is an effective drug for asthma, there has been increasing concern regarding neuropsychiatric (NP) adverse reactions. However, evidence for this association is not sufficient, especially in adults.
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue! Risk of #Neuropsychiatric #Diseases According to the Use of a #Leukotriene #Receptor #Antagonist in Middle-Aged and Older Adults with #Asthma: A Nationwide Population-Based Study Using Health Claims Data in Korea https://t.co/nG4ZnSYgQt https://t.co/ELyItkQPGA
-
-
Mashup Score: 1Guidelines for dementia and age-related cognitive changes - 3 year(s) ago
While these guidelines are aimed at psychologists, primary care doctors are often the first ones to evaluate a patient who may have dementia.
Source: www.mdedge.comCategories: Latest Headlines, PsychiatryTweet-
Utilizing #neuropsychiatric testing and defining severity will be essential going forward in light of the growing dementia epidemic. https://t.co/Vsz6Bea0mR https://t.co/Y77KfqIzLE
-
-
Mashup Score: 0Do adolescents develop CNS autoimmunity after COVID-19? - 3 year(s) ago
The researchers examined three pediatric patients who were infected with SARS-CoV-2 and, over a period of 5 months in 2020, were admitted to the hospital.
Source: www.mdedge.comCategories: Latest Headlines, PediatricsTweet-
Recent research suggests that some pediatric patients who develop #neuropsychiatric symptoms from COVID-19 may have intrathecal antineural SARS-CoV-2 autoantibodies, which may hint at CNS #autoimmunity in these patients. https://t.co/aqq5s17tsp Via @JAMANeuro https://t.co/3c7Qbu4xZk
-
-
Mashup Score: 1Do adolescents develop CNS autoimmunity after COVID-19? - 3 year(s) ago
The researchers examined three pediatric patients who were infected with SARS-CoV-2 and, over a period of 5 months in 2020, were admitted to the hospital.
Source: www.mdedge.comCategories: Latest Headlines, PsychiatryTweet-
Recent research suggests that some pediatric patients who develop #neuropsychiatric symptoms from COVID-19 may have intrathecal antineural SARS-CoV-2 autoantibodies, which may hint at CNS autoimmunity in these patients. https://t.co/enoKMnZjtZ Via @JAMANeuro https://t.co/vL5vooJnDh
-
Good news, @CellSymposia The Biology of #Neuropsychiatric Disorders #CSNeuropsychiatric2022 abstract deadline has been extended until Feb 25. If necessary, we can switch to our online conference platform, so you can submit your abstracts in confidence. https://t.co/1TnZ4hSVeK https://t.co/jgEKF2VQwm